±èÂù
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ´ëÀå¾Ï, ºñ´¢±â¾Ï(½ÅÀå¾Ï, ¹æ±¤¾Ï)
Á÷
ˤ
: ºÎ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
42
ÇØ¿Ü
Targeting actomyosin contractility suppresses malignant phenotypes of acute myeloid leukemia cells. Int J Mol Sci 2020 (IF 4.183)
41
ÇØ¿Ü
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with PD-1 blockade to suppress peritoneal carcinomatosis in colon cancer. J Immunother Cancer 2020 (IF 9.9)
40
ÇØ¿Ü
Kim CG*, Kim C*, Yoon SE*, Kim KH, Choi SJ, Kang B, Kim HR, Park SH, Shin EC, Kim DJ, Chon HJ, Choi HJ, Lim HY. Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma. Journal of Hepatology 2020 (IF 20.582)
39
ÇØ¿Ü
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental Molecular Medicine 2020 (IF 4.743)
38
ÇØ¿Ü
REACH-2: First biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma. Chinese Clinical Oncology 2020 (Editorial commentary)
37
ÇØ¿Ü
STING signaling is a potential immunotherapeutic target in colorectal cancer. Journal of Cancer 2019 (In Press, IF 3.182)
36
ÇØ¿Ü
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade. J Clin Invest 2019 (E-pub, IF 12.282)
35
ÇØ¿Ü
Randomized phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer. European Journal of Cancer 2019 (IF 7.191)
34
ÇØ¿Ü
Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune checkpoint blockade. Clinical Cancer Research 2019;25(5):1612-1623 (IF 10.199)
33
ÇØ¿Ü
The Clinical Implications of FDG-PET/CT Differ According to Histology in Advanced Gastric Cancer. Gastric Cancer 2018 (IF 5.454)
1
2
3
4
5
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729